Financial Sense Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-64,641
| Closed | -$6.13M | – | 126 |
|
|
2024
Q1 | $6.13M | Buy |
+64,641
| New | +$6.13M | 2.02% | 12 |
|
|
2022
Q4 | – | Sell |
-4,146
| Closed | -$329K | – | 101 |
|
|
2022
Q3 | $329K | Sell |
4,146
-139
| -3% | -$11K | 0.14% | 67 |
|
|
2022
Q2 | $318K | Sell |
4,285
-805
| -16% | -$59.7K | 0.12% | 78 |
|
|
2022
Q1 | $457K | Buy |
5,090
+531
| +12% | +$47.7K | 0.17% | 45 |
|
|
2021
Q4 | $510K | Sell |
4,559
-3
| -0.1% | -$336 | 0.18% | 69 |
|
|
2021
Q3 | $574K | Sell |
4,562
-131
| -3% | -$16.5K | 0.19% | 70 |
|
|
2021
Q2 | $635K | Sell |
4,693
-541
| -10% | -$73.2K | 0.2% | 69 |
|
|
2021
Q1 | $710K | Sell |
5,234
-755
| -13% | -$102K | 0.24% | 66 |
|
|
2020
Q4 | $843K | Sell |
5,989
-3,926
| -40% | -$553K | 0.31% | 55 |
|
|
2020
Q3 | $1.11M | Buy |
9,915
+3,506
| +55% | +$391K | 0.44% | 39 |
|
|
2020
Q2 | $718K | Buy |
6,409
+2,290
| +56% | +$257K | 0.26% | 47 |
|
|
2020
Q1 | $319K | Sell |
4,119
-161
| -4% | -$12.5K | 0.14% | 73 |
|
|
2019
Q4 | $407K | Buy |
4,280
+255
| +6% | +$24.2K | 0.15% | 61 |
|
|
2019
Q3 | $307K | Hold |
4,025
| – | – | 0.15% | 58 |
|
|
2019
Q2 | $353K | Buy |
4,025
+1,270
| +46% | +$111K | 0.16% | 51 |
|
|
2019
Q1 | $249K | Buy |
+2,755
| New | +$249K | 0.11% | 52 |
|
|
2018
Q4 | – | Sell |
-4,152
| Closed | -$398K | – | 72 |
|
|
2018
Q3 | $398K | Buy |
4,152
+838
| +25% | +$80.3K | 0.17% | 53 |
|
|
2018
Q2 | $315K | Buy |
3,314
+151
| +5% | +$14.4K | 0.22% | 47 |
|
|
2018
Q1 | $277K | Buy |
3,163
+1
| +0% | +$88 | 0.13% | 64 |
|
|
2017
Q4 | $268K | Buy |
3,162
+59
| +2% | +$5K | 0.12% | 63 |
|
|
2017
Q3 | $269K | Buy |
+3,103
| New | +$269K | 0.14% | 60 |
|